Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
Baicalin n-butyl ester alleviates inflammatory bowel disease and inhibits pyroptosis through the ROS/ERK/P-ERK/NLRP3 pathway in vivo and in vitro.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Guo Mengru, Wu Huining, Zhang Jin, Zhao Linlu, He Jieyi, Yu Zhichao, Ma Xingbin, Yong Yanhong, Li Youquan, Ju Xianghong, Liu Xiaoxi
Аннотация
BACKGROUND: Baicalin is a flavonoid extracted from dried roots of the plant Scutellariabaicalensis. Baicalin n-butyl ester (BNE) is a flavonoid obtained by esterification of baicalin and has anti-inflammatory and antioxidant effects.
PURPOSE: The therapeutic efficacy and potential mechanism of BNE in inflammatory bowel disease remain unclear. This study investigated the effects and underlying mechanisms of BNE in ulcerative colitis.
METHODS: Dextran sulfate sodium (DSS) was used to construct a mouse model of ulcerative colitis, and mice were given intragastric administration of BNE. During the experiment, the changes of body weight and hematochezia of mice were observed. At the end of administration, the levels of inflammatory factors, colonic microbial changes and pyroptosis of colonic cells were measured. Mouse intestinal epithelial cells were stimulated by lipopolysaccharide/adenosine-5'-triphosphate to establish an in vitro model. ELISA, qRT-PCR and immunoblotting were used to explore the effect and mechanism of BNE on pyroptosis.
RESULTS: In vivo, BNE drastically attenuated ulcerative colitis symptoms by relieving body weight loss, a decline in colon length, and destruction of colon tissue structure. BNE also reduced the secretion of pro-inflammatory cytokines, including IL-1β, IL-18, and TNF-α, and reactive oxygen species (ROS). Furthermore, 16S rRNA sequencing analyses of gut microbiota revealed that BNE reversed gut microbiota dysbiosis by reducing the abundance of unclassified-Clostridia-UCG-014 and increasing that of Lachnospiraceae. BNE also inhibited cell pyroptosis in mice with DSS-induced colitis. In vitro analyses showed that BNE decreased the secretion of IL-1β, IL-18, TNF-α, and ROS in lipopolysaccharide/adenosine-5'-triphosphate-stimulated mouse intestinal epithelial cells, and it inhibited pyroptosis mediated by oligomeric domain-like receptor protein 3 (NLRP3). Addition of ROS scavenger and ERK inhibitor further confirmed that BNE down-regulated ROS and inhibited the phosphorylation of ERK, thus inhibiting NLRP3-mediated cell pyroptosis. The magnetic beads pull-down assay showed that BNE had the capacity to bind directly to the ERK proteinin MODE-K cells.
CONCLUSION: BNE protects against colitis by increasing the abundance of Lachnospiraceae in vivo and suppressing pyroptosis via binding ERK protein and inhibiting ROS/ERK/P-ERK/NLRP3 in vivo and in vitro.
PURPOSE: The therapeutic efficacy and potential mechanism of BNE in inflammatory bowel disease remain unclear. This study investigated the effects and underlying mechanisms of BNE in ulcerative colitis.
METHODS: Dextran sulfate sodium (DSS) was used to construct a mouse model of ulcerative colitis, and mice were given intragastric administration of BNE. During the experiment, the changes of body weight and hematochezia of mice were observed. At the end of administration, the levels of inflammatory factors, colonic microbial changes and pyroptosis of colonic cells were measured. Mouse intestinal epithelial cells were stimulated by lipopolysaccharide/adenosine-5'-triphosphate to establish an in vitro model. ELISA, qRT-PCR and immunoblotting were used to explore the effect and mechanism of BNE on pyroptosis.
RESULTS: In vivo, BNE drastically attenuated ulcerative colitis symptoms by relieving body weight loss, a decline in colon length, and destruction of colon tissue structure. BNE also reduced the secretion of pro-inflammatory cytokines, including IL-1β, IL-18, and TNF-α, and reactive oxygen species (ROS). Furthermore, 16S rRNA sequencing analyses of gut microbiota revealed that BNE reversed gut microbiota dysbiosis by reducing the abundance of unclassified-Clostridia-UCG-014 and increasing that of Lachnospiraceae. BNE also inhibited cell pyroptosis in mice with DSS-induced colitis. In vitro analyses showed that BNE decreased the secretion of IL-1β, IL-18, TNF-α, and ROS in lipopolysaccharide/adenosine-5'-triphosphate-stimulated mouse intestinal epithelial cells, and it inhibited pyroptosis mediated by oligomeric domain-like receptor protein 3 (NLRP3). Addition of ROS scavenger and ERK inhibitor further confirmed that BNE down-regulated ROS and inhibited the phosphorylation of ERK, thus inhibiting NLRP3-mediated cell pyroptosis. The magnetic beads pull-down assay showed that BNE had the capacity to bind directly to the ERK proteinin MODE-K cells.
CONCLUSION: BNE protects against colitis by increasing the abundance of Lachnospiraceae in vivo and suppressing pyroptosis via binding ERK protein and inhibiting ROS/ERK/P-ERK/NLRP3 in vivo and in vitro.
Предметные рубрики MeSH
AnimalsNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisFlavonoidsReactive Oxygen SpeciesMiceColitis, UlcerativeDextran SulfateMice, Inbred C57BLMaleDisease Models, AnimalMAP Kinase Signaling SystemGastrointestinal MicrobiomeAnti-Inflammatory AgentsColonExtracellular Signal-Regulated MAP KinasesInflammatory Bowel DiseasesSignal Transduction